期刊文献+

乌司他丁对无心跳兔供肺的保护作用 被引量:4

Protective effects of ulinastatin during non-heart-beating donors lung transplantation
原文传递
导出
摘要 目的研究乌司他丁(UTI)对无心跳供者(NHBD)供肺的保护作用及其作用机制。方法选取新西兰大白兔作为NHBD供肺离体再灌注实验的供、受者,随机将兔分为A、B、C三组,每组各5对。A组为对照组,先使供者发生失血性休克并维持30min,然后静脉注射氯化钾使心脏停跳,行胸外心脏按压以维持循环10min后,原位冷却供肺,并经肺动脉灌注4℃的低钾右旋糖苷(LPD)液,取出供肺并冷保存5h,最后将供肺与受者建立NHBD供肺离体再灌注模型,供肺再灌注时间为90min;B组为UTI灌注组,供肺灌注时,LPD液中加入UTI(500000U/kg),其余处理同A组;C组为UTI预处理组,供者在休克期间静脉注射UTI(50000U/kg)行预处理,其余处理同B组。再灌注后1、30、60和90min4个时点,监测供肺的血氧分压(PO2)和气道峰压(PAwP)。再灌注结束后,计算供肺组织湿/干重量比(W/D),并制备供肺组织匀浆,采用分光光度法和硫代巴比妥酸法测定髓过氧化物酶(MPO)和丙二醛(MDA)的活性;采用逆转录聚合酶链反应检测白细胞介素-8(IL-8)和细胞间粘附分子-1(ICAM-1)mRNA的表达水平;观察供肺病理组织学的变化。结果再灌注后1、30、60和90min,B组和C组的PO2、PAwP以及供肺W/D与A组比较,差异均有统计学意义(P〈0.05),但B组与c组间的差异无统计学意义;再灌注结束后,B组和C组供肺组织匀浆中MPO和MDA的活性均显著低于A组(P〈0.05),IL8和IcAM-1mRNA的表达水平较A组显著下降(P〈0.05);C组MPO和MDA的活性低于B组(P〈0.05),IL-8和ICAM-1mRNA的表达水平较B组显著下降(P〈0.05);三组供肺组织均存在不同程度的损伤,其中A组损伤最重,C组最轻。结论灌注液中加人大剂量的UTI对NHBD供肺具有保护作用,尤其在NHBD休克期间注射UTI预处理。这可能与UTI能清除氧自由基,抑制炎症细胞因子的释放、抑制中性粒细胞激活从而减轻缺血再灌注损伤有关。 Objective To investigate the protective effects of treatment with ulinastatin (UTI) during rabbit non-heart-beating donors lung transplantation, and explore the possible mechanism. Methods Thirty rabbits were divided randomly into three groups: group A as control group, group B as UTI flushing group, and group C as UTI preconditioning plus flushing group. In group A donors were exsanguinated to maintain hypotension for 30 min before intravenous injection of potassium chloride to make heart arrest. After a period of 1 h warm ischemia in situ, topical cooling was executed. Meanwhile, the donor lungs were antegradely flushed through pulmonary arteries with lowpotassium-dextron (LPD) solution at 4 ℃. After flushing in situ, lung-heart blocks were harvested and store at 4 ℃ for another 5 h, then perfused for 90 min in isolated, ventilated, blood-perfused rabbit lung models. Pulmonary venous blood samples were collected for blood gas analysis at 1st, 30th, 60th, and 90th min after initiation of reperfusion. At the same time, PAwP was recorded respectively. Lung samples were obtained at the end of reperfusion. The pulmonary water index (W/D), tissue myeloperoxidase (MPO) activity, tissue malondialdehyde (MDA) content, and mRNA expression of IL-8 and ICAM-1 were measured. Microscopic examination of donor lungs was conducted. In group B, the same procedures were conducted as in group A except for adding UTI (500 000 U/L) to LPD solution. In group C, except that a bolus of UTI (50 000 U/kg) was given to donors intravenously during hypotension, the same procedures were conducted as in group B. Results (1) In all three groups, there were same tendencies of gradually decreasi of PO2 levels; and as compared with groups B and C, PO2 levels in group A were significantly redaced. Similar results could be observed in PAwP values, but the tendency was increasing. (2) The level of W/D, MPO activity, MDA content, and the mRNA expression of IL-8 and ICAM-1 in groups B and C were decreased as compared with group A (P〈0. 05). The MPO activity, MDA content, and the mRNA expression of IL-8 and ICAM-1 in group C were decreased evidently as compared with group B (P〈0. 05). (3) The microscopic change of donor lung tissues in group A was more severe than in groups B and C, and that in group C was lessen than in group B. Conclusions A big dose of UTI flushing pulmonary artery had a protective effect on graft function. UTI preconditioning during hypotension can further strengthen this effect, partly by decreasing the level of oxygen free radicals, the mRNA expression of IL-8 and ICAM-1 in lung tissues, and inhibiting the activation of PMN to alleviate the ischemia-reperfusioninduced inflammation.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2009年第4期218-221,共4页 Chinese Journal of Organ Transplantation
关键词 肺移植 再灌注损伤 乌司他丁 Lung transplantation Reperfusion injury Ulinastatin
  • 相关文献

参考文献8

  • 1Ware LB, Wang Y, Fang X, et aI. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet, 2002, 360(9333) :619-620.
  • 2Sun JL, Zhang XQ, Yu ZG, et al. Effects of ulinastatin on postoperative systemic inflammatory response of recipients of rat small bowel transplantation. Transplant Proc, 2006, 38 (6) : 1803-1804.
  • 3Itabashi K, Ito Y, Takahashi T, et al. Protective effects of urinary trypsin inhibitor (UTI) on hepatic mierovasculature in hypotensive brain-dead rats. Eur Surg Res, 2002,34(4):330- 338.
  • 4洪勇,古维立,曹杰,夏杰.乌司他丁对肝脏冷保存损伤的保护作用研究[J].中国危重病急救医学,2007,19(7):398-400. 被引量:4
  • 5Binns OA, de Lima NF, Buchanan SA, et al. Neutrophil endopeptidase inhibitor improves pulmonary function during reperfusion after eighteen-hour preservation. J Thorac Cardiovase Surg, 1996, 112(3):607-613.
  • 6邓文锋,于立新,余玉明,苗芸.乌司他丁减轻移植肾热缺血损伤的临床研究[J].中华泌尿外科杂志,2004,25(11):739-741. 被引量:7
  • 7Yano T, Anraku S, Nakayama R, Ushijima K. Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemiareperfusion injury in rats. Anesthesiology, 2003, 98 (2) : 465-473.
  • 8de Antonio DG, Marcos R, Laporta R, et al. Results of clinical lung transplant from uncontrolled non-heart-beating donors. J Heart Lung Transplant, 2007, 26(5):529-534.

二级参考文献20

共引文献9

同被引文献59

  • 1王瑞珂,赵双平,杨新平,周智广.乌司他丁在酸吸入性急性肺损伤早期治疗中的作用[J].中南大学学报(医学版),2004,29(3):305-308. 被引量:28
  • 2邵义明,张良清,邓烈华,姚华国.乌司他丁对全身炎症反应综合征的治疗作用[J].中国危重病急救医学,2005,17(4):228-230. 被引量:155
  • 3张全,曹丽叶,程树杰,李广波,张彩菊.乌司他丁对急性坏死性胰腺炎合并肺损伤肺内细胞间黏附分子-1的基因表达及肺损伤的影响[J].中华实验外科杂志,2007,24(1):62-64. 被引量:9
  • 4Nunez JR, Varela A, del RF, et al. Bipulmonary transplants with lungs obtained from two non-heart-beating donors who died out of hospital. J Thorac Cardiovase Surg, 2004,127:297-299.
  • 5Rega FR, Vanaudenaerde BM, Wuyts WA, et al. IL-lbeta in bronchial lavage fluid is a non-invasive marker that predicts the viability of the pulmonary gra- from the non-heart-beating donor. J Heart Lung Transplant, 2005,24:20-28.
  • 6Lascano EC, Bertolotti A, Gomez CB, et al. Failure of IL-8 to assess early reperfusion injury following lung transplantation of cardiac death donor pigs. Transpl Int, 2009,22:574-582.
  • 7Love RB, Stringham JC, Chomiak PN, et al. Successful lung transplantation using a non-heart-beating donor. J Heart Lung Transplant, 1995,14:S88 (abstract).
  • 8Oto T, Lewey B, McEgan R, et al. A practical approach to clinical lung transplantation from a Maastricht Category III donor with cardiac death. J Heart Lung Transplant,2007,26:196-199.
  • 9Mason DP, Murthy SC, Gonzalez-Stawinski GV, et al. Early experience with lung transplantation using donors after cardiac death. J Heart Lung Transplant, 2008,27:561-563.
  • 10Snell GI, Levvey B J, Oto T, et al. Early lung transplantation success utilizing controlled donation after cardiac death donors. Am J Transplant, 2008,8:1282-1289.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部